EDF Health

Shining a (partly shaded) light on nanomaterials that present “substantial risk”

Richard Denison, Ph.D., is a Senior Scientist.

Section 8(e) of the Toxic Substances Control Act (TSCA) requires any company that manufactures, imports, processes or distributes chemicals in the U.S. to notify EPA within 30 days if it obtains new information that “reasonably supports the conclusion that such substance or mixture presents a substantial risk of injury to health or the environment.”  Are there Section 8(e) notices for nanomaterials? Read More »

Posted in Health policy, Regulation / Tagged , , | Comments are closed

A. Length, B. Metals, C. Oxygen, D. Surface, or E. All of the Above?

Cal Baier-Anderson, Ph.D., is a Health Scientist.

The manufacture of carbon nanotubes (CNTs) is a very complicated business.  Different production processes leave behind different kinds of metal catalysts, which yield differences in physical and chemical – as well as toxicological – properties of the CNTs.  Read More »

Posted in Health science, Nanotechnology / Tagged , | Comments are closed

EPA’s Nano Consent Order, Part II: What About the Lifecycle?

Richard Denison, Ph.D., is a Senior Scientist.

Since my first post concerning EPA’s Consent Order, I’ve been reflecting further on the management conditions it imposes – or, more accurately, on what conditions it doesn’t impose.  The Order’s only such conditions address potential worker exposure.  What about the rest of the nanomaterial’s lifecycle? Read More »

Posted in Health policy, Nanotechnology, TSCA reform / Tagged , , | Comments are closed

EPA’s Nano Consent Order, Part I: “Sanitized” Transparency is Still Very Revealing

Richard Denison, Ph.D., is a Senior Scientist.

[Part II of this post is available here.]

Word hit the street today that EPA intends to make public a “sanitized” version of a Consent Order it has negotiated with a producer of multiwalled carbon nanotubes (MWCNTs).  [A link will be provided once available.]  We obtained a copy of the Order, which has redacted all information claimed confidential by the company involved.  What can we learn from this well-scrubbed Order? Read More »

Posted in Health policy, Nanotechnology, TSCA reform / Tagged , , | Comments are closed

The Nano Risk Framework Gets Ready for Shanghai

John Balbus, M.D., M.P.H., is Chief Health Scientist.

At its most recent meeting a few weeks ago, the US Technical Advisory Group (TAG) to the International Standards Organization (ISO) Technical Committee on Nanotechnologies approved a motion to have ISO develop a Technical Report based on the EDF-Dupont Nano Risk Framework (NRF). Or to put it another way in acronym-laden Washington-speak, the US TAG to the ANSI-accredited ISO TC229 approved a TR based on the EDF-DD NRF. Read More »

Posted in Health policy, International, Nanotechnology / Tagged , , | Read 1 Response

Giving new meaning to the phrase “Insuring the safety of nanomaterials”

Richard Denison, Ph.D., is a Senior Scientist.

The insurance industry is out in front on nanotechnology yet again.  As the giant reinsurer Swiss Re did way back in May 2004 with its groundbreaking report Nanotechnology: Small matter, many unknowns, it is once again the insurance industry sounding an early alarm about nanomaterials.  In this case, it’s the Continental Western Insurance Group (CWG), which has just announced that it will exclude coverage for “the, as of yet, unknown and unknowable risks created by the products and processes that involve nanotubes.” Read More »

Posted in Health policy, Nanotechnology / Tagged , | Comments are closed